Steven C. Crouse
CIK: 0002065241
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (19 total)
- Aug 17, 2026TECH
BIO-TECHNE Corp
Award(A)DirectRestricted Stock Units
8.7K shares- - Aug 17, 2026TECH
BIO-TECHNE Corp
Award(A)DirectRestricted Stock Units
14.1K shares- - Aug 15, 2026TECH
BIO-TECHNE Corp
Exercise(M)Direct5.4K shares- - Aug 15, 2026TECH
BIO-TECHNE Corp
Tax Payment(F)Direct1.9K shares at avg. $72.40$141K - Jun 17, 2026OABI
OmniAb, Inc.
Award(A)DirectStock Option (right to buy)
40K shares- - Jun 17, 2026OABI
OmniAb, Inc.
Exercise(M)Direct20K shares- - Jun 17, 2026OABI
OmniAb, Inc.
Award(A)DirectRestricted Stock Units
20K shares- - Jun 2, 2026TECH
BIO-TECHNE Corp
Exercise(M)Direct600 shares- - Jun 2, 2026TECH
BIO-TECHNE Corp
Tax Payment(F)Direct216 shares at avg. $49.77$11K - May 1, 2026TECH
BIO-TECHNE Corp
Tax Payment(F)Direct311 shares at avg. $55.02$17K - May 1, 2026TECH
BIO-TECHNE Corp
Exercise(M)Direct794 shares- - Apr 21, 2026OABI
OmniAb, Inc.
Exercise(M)Direct13.3K shares- - Mar 2, 2026TECH
BIO-TECHNE Corp
Award(A)DirectStock Option (right to buy)
1.9K shares- - Mar 2, 2026TECH
BIO-TECHNE Corp
Award(A)DirectPerformance Restricted Stock Units
2.4K shares- - Mar 2, 2026TECH
BIO-TECHNE Corp
Award(A)DirectRestricted Stock Units
735 shares- - Jun 17, 2025OABI
OmniAb, Inc.
Award(A)DirectStock Option (right to buy)
40K shares- - Jun 17, 2025OABI
OmniAb, Inc.
Award(A)DirectRestricted Stock Units
20K shares- - Apr 21, 2025OABI
OmniAb, Inc.
Award(A)DirectStock Option (right to buy)
80K shares- - Apr 21, 2025OABI
OmniAb, Inc.
Award(A)DirectRestricted Stock Units
40K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 17, 2026 |  TECH BIO-TECHNE Corp | Award(A) Restricted Stock Units | 8,702 | - | - | Direct |
| Aug 17, 2026 | TECH BIO-TECHNE Corp | Award(A) Restricted Stock Units | 14,140 | - | - | Direct |
| Aug 15, 2026 | TECH BIO-TECHNE Corp | Exercise(M) | 5,423 | - | $0 | Direct |
| Aug 15, 2026 | TECH BIO-TECHNE Corp | Tax Payment(F) | 1,947 | $72.40 | $140,963 | Direct |
| Jun 17, 2026 |  OABI OmniAb, Inc. | Award(A) Stock Option (right to buy) | 40,000 | - | - | Direct |
| Jun 17, 2026 | OABI OmniAb, Inc. | Exercise(M) | 20,000 | - | $0 | Direct |
| Jun 17, 2026 | OABI OmniAb, Inc. | Award(A) Restricted Stock Units | 20,000 | - | - | Direct |
| Jun 2, 2026 | TECH BIO-TECHNE Corp | Exercise(M) | 600 | - | $0 | Direct |
| Jun 2, 2026 | TECH BIO-TECHNE Corp | Tax Payment(F) | 216 | $49.77 | $10,750 | Direct |
| May 1, 2026 | TECH BIO-TECHNE Corp | Tax Payment(F) | 311 | $55.02 | $17,111 | Direct |
| May 1, 2026 | TECH BIO-TECHNE Corp | Exercise(M) | 794 | - | $0 | Direct |
| Apr 21, 2026 | OABI OmniAb, Inc. | Exercise(M) | 13,333 | - | $0 | Direct |
| Mar 2, 2026 | TECH BIO-TECHNE Corp | Award(A) Stock Option (right to buy) | 1,911 | - | - | Direct |
| Mar 2, 2026 | TECH BIO-TECHNE Corp | Award(A) Performance Restricted Stock Units | 2,387 | - | - | Direct |
| Mar 2, 2026 | TECH BIO-TECHNE Corp | Award(A) Restricted Stock Units | 735 | - | - | Direct |
| Jun 17, 2025 | OABI OmniAb, Inc. | Award(A) Stock Option (right to buy) | 40,000 | - | - | Direct |
| Jun 17, 2025 | OABI OmniAb, Inc. | Award(A) Restricted Stock Units | 20,000 | - | - | Direct |
| Apr 21, 2025 | OABI OmniAb, Inc. | Award(A) Stock Option (right to buy) | 80,000 | - | - | Direct |
| Apr 21, 2025 | OABI OmniAb, Inc. | Award(A) Restricted Stock Units | 40,000 | - | - | Direct |
1-19 of 19 transactions
About Crouse Steven C.
Crouse Steven C. (SEC CIK 0002065241) files insider reports with the SEC as President - Diag & Spatial Bi of BIO-TECHNE Corp (TECH) and Director of OmniAb, Inc. (OABI).
Signal8 holds 11 ownership filings by Crouse Steven C. (2 Form 3, 9 Form 4), filed between Apr 21, 2025 and Aug 19, 2026. Those filings report 19 transactions, from Apr 21, 2025 to Aug 17, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Crouse Steven C.'s filings is in MINNEAPOLIS, MN.
Recent filings by Crouse Steven C.
- Aug 17, 2026: Grants or awards of TECH derivative securities (2 lines, Form 4, code A).
- Aug 15, 2026: Option exercise of TECH shares (Form 4, code M).
- Aug 15, 2026: Tax withholding of TECH shares (Form 4, code F).
- Jun 17, 2026: Grant or award of OABI derivative securities (Form 4, code A).
- Jun 17, 2026: Option exercise of OABI shares (Form 4, code M).
Other insiders filing for BIO-TECHNE Corp (TECH)
- Hippel James, CFO
- Geist William, PRESIDENT, PROTEIN SCIENCES
- Kelderman Kim, Chief Executive Officer
- Bohnen Shane, SVP - General Counsel
- Vessey Rupert, Director
- Seth Alpna, Director